Personalized management of pheochromocytoma and paraganglioma

S Nölting, N Bechmann, D Taieb… - Endocrine …, 2022 - academic.oup.com
Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working …

JWM Lenders, MN Kerstens, L Amar… - Journal of …, 2020 - journals.lww.com
Phaeochromocytoma and paraganglioma (PPGL) are chromaffin cell tumours that require
timely diagnosis because of their potentially serious cardiovascular and sometimes life …

European association of nuclear medicine practice guideline/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of …

D Taïeb, RJ Hicks, E Hindié, BA Guillet… - European journal of …, 2019 - Springer
Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …

Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants

D Taïeb, GB Wanna, M Ahmad… - The Lancet Diabetes & …, 2023 - thelancet.com
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase
subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck …

Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the era of precision medicine

S Nölting, M Ullrich, J Pietzsch, CG Ziegler… - Cancers, 2019 - mdpi.com
Pheochromocytomas and paragangliomas (PCC/PGLs) are rare, mostly catecholamine-
producing neuroendocrine tumors of the adrenal gland (PCCs) or the extra-adrenal …

Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT

Y Sanli, I Garg, A Kandathil, T Kendi… - American Journal of …, 2018 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to provide a review of the use of 68Ga
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …

Performance of 68Ga-DOTA–conjugated somatostatin receptor–targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review …

S Han, CH Suh, S Woo, YJ Kim… - Journal of Nuclear …, 2019 - Soc Nuclear Med
We performed a systematic review and metaanalysis of the performance of 68Ga-DOTA–
conjugated somatostatin receptor–targeting peptide (68Ga-DOTA-SST) PET in the detection …

Imaging of pheochromocytoma and paraganglioma

JA Carrasquillo, CC Chen, A Jha, A Ling… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Imaging plays a critical role in the management of pheochromocytomas and
paragangliomas and often guides treatment. The discovery of susceptibility genes …

The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and/or unresectable pheochromocytoma …

L Fishbein, J Del Rivero, T Else, JR Howe, SL Asa… - Pancreas, 2021 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the medical management and surveillance of metastatic and …

The diagnosis and clinical significance of paragangliomas in unusual locations

SL Asa, S Ezzat, O Mete - Journal of clinical medicine, 2018 - mdpi.com
Paragangliomas are neuroendocrine neoplasms, derived from paraganglia of the
sympathetic and parasympathetic nervous systems. They are most commonly identified in …